Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zomedica Corp. (ZOMDF) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Zomedica Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 1684144.
Total stock buying since 2017: $1,077,208.
Total stock sales since 2017: $5,047,194.
Total stock option exercises since 2017: $3,710,568.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 7,203,072 | $404,762 | 0 | $0 | 0 | $0 |
2024 | 2,450,000 | $345,897 | 0 | $0 | 0 | $0 |
2023 | 650,000 | $114,049 | 0 | $0 | 0 | $0 |
2021 | 250,000 | $112,500 | 4,957,926 | $4,607,549 | 4,951,526 | $1,340,902 |
2020 | 625,000 | $100,000 | 0 | $0 | 0 | $0 |
2019 | 0 | $0 | 0 | $0 | 394,735 | $599,995 |
2018 | 0 | $0 | 205,000 | $439,645 | 1,708,896 | $869,671 |
2017 | 0 | $0 | 0 | $0 | 750,000 | $900,000 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-08 | 2,116,787 | $84,169 | 0 | $0 | 0 | $0 |
2025-05 | 704,300 | $33,006 | 0 | $0 | 0 | $0 |
2025-03 | 4,381,985 | $287,587 | 0 | $0 | 0 | $0 |
2024-11 | 600,000 | $72,700 | 0 | $0 | 0 | $0 |
2024-09 | 100,000 | $12,500 | 0 | $0 | 0 | $0 |
2024-08 | 200,000 | $27,099 | 0 | $0 | 0 | $0 |
2024-06 | 1,025,000 | $155,299 | 0 | $0 | 0 | $0 |
2024-05 | 525,000 | $78,299 | 0 | $0 | 0 | $0 |
2023-12 | 100,000 | $16,500 | 0 | $0 | 0 | $0 |
2023-11 | 350,000 | $59,149 | 0 | $0 | 0 | $0 |
2023-05 | 200,000 | $38,400 | 0 | $0 | 0 | $0 |
2021-11 | 250,000 | $112,500 | 0 | $0 | 0 | $0 |
2021-06 | 0 | $0 | 3,318,750 | $2,713,268 | 3,318,750 | $703,187 |
2021-05 | 0 | $0 | 19,444 | $20,610 | 19,444 | $2,916 |
2021-04 | 0 | $0 | 1,613,332 | $1,866,625 | 1,613,332 | $634,799 |
2021-02 | 0 | $0 | 6,400 | $7,046 | 0 | $0 |
2020-07 | 625,000 | $100,000 | 0 | $0 | 0 | $0 |
2019-03 | 0 | $0 | 0 | $0 | 394,735 | $599,995 |
2018-12 | 0 | $0 | 0 | $0 | 26,900 | $32,280 |
2018-11 | 0 | $0 | 0 | $0 | 175,000 | $210,000 |
2018-10 | 0 | $0 | 0 | $0 | 200,000 | $240,000 |
2018-08 | 0 | $0 | 200,000 | $430,000 | 0 | $0 |
2018-06 | 0 | $0 | 1,500 | $2,885 | 0 | $0 |
2018-05 | 0 | $0 | 3,500 | $6,760 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-08-12 | Klass Russell Kevin (Sr Vice President, Sales) | Buy | 995,341 | .04 | 39,813 |
2025-08-11 | Klass Russell Kevin (Sr Vice President of Sales) | Buy | 560,723 | .04 | 21,928 |
2025-08-08 | Klass Russell Kevin (Sr Vice President of Sales) | Buy | 500,000 | .04 | 20,000 |
2025-05-21 | Blair Anthony K (COO) | Buy | 100,000 | .05 | 5,000 |
2025-05-19 | Dehaan-fullerton Karen (General Counsel/Corporate Secy) | Buy | 104,300 | .05 | 5,006 |
2025-05-19 | Powers Johnny D | Buy | 500,000 | .05 | 23,000 |
2025-03-17 | Klass Russell Kevin (Sr Vice President of Sales) | Buy | 699,980 | .07 | 48,998 |
2025-03-17 | Jordan Scott (Chief Financial Officer) | Buy | 300,000 | .06 | 18,600 |
2025-03-17 | Macleod Christopher Ross | Buy | 143,000 | .06 | 8,437 |
2025-03-17 | Williams Rodney James | Buy | 200,000 | .07 | 13,800 |
2025-03-17 | Rowe Jeffrey M | Buy | 1,439,005 | .07 | 97,852 |
2025-03-17 | Blair Anthony K (COO) | Buy | 500,000 | .06 | 30,000 |
2025-03-17 | Heaton Larry C Ii (CEO) | Buy | 500,000 | .06 | 29,000 |
2025-03-17 | Powers Johnny D | Buy | 500,000 | .07 | 34,000 |
2024-11-11 | Klass Russell Kevin (Vice President of Sales) | Buy | 500,000 | .12 | 60,500 |
2024-11-11 | Heaton Larry C Ii (CEO) | Buy | 100,000 | .12 | 12,200 |
2024-09-05 | Heaton Larry C Ii (CEO) | Buy | 100,000 | .12 | 12,500 |
2024-08-28 | Powers Johnny D | Buy | 100,000 | .13 | 12,900 |
2024-08-20 | Blair Anthony K (COO) | Buy | 100,000 | .14 | 14,199 |
2024-06-12 | Klass Russell Kevin (Vice President of Sales) | Buy | 299,993 | .15 | 46,498 |
2024-06-11 | Klass Russell Kevin (Vice President of Sales) | Buy | 500,000 | .15 | 75,000 |
2024-06-10 | Klass Russell Kevin (Vice President of Sales) | Buy | 200,007 | .15 | 30,001 |
2024-06-10 | Donato Peter (Chief Financial Officer) | Buy | 25,000 | .15 | 3,800 |
2024-05-17 | Powers Johnny D | Buy | 100,000 | .17 | 17,500 |
2024-05-16 | Powers Johnny D | Buy | 25,000 | .18 | 4,600 |
2024-05-14 | Powers Johnny D | Buy | 50,000 | .14 | 7,000 |
2024-05-13 | Blair Anthony K (COO) | Buy | 150,000 | .14 | 21,000 |
2024-05-13 | Heaton Larry C Ii (CEO) | Buy | 100,000 | .14 | 14,199 |
2024-05-13 | Powers Johnny D | Buy | 100,000 | .14 | 14,000 |
2023-12-15 | Powers Johnny D | Buy | 100,000 | .17 | 16,500 |
2023-11-17 | Heaton Larry C Ii (CEO) | Buy | 100,000 | .17 | 16,600 |
2023-11-17 | Powers Johnny D | Buy | 100,000 | .17 | 16,600 |
2023-11-15 | Powers Johnny D | Buy | 150,000 | .17 | 25,949 |
2023-05-26 | Heaton Larry C Ii (CEO) | Buy | 100,000 | .19 | 19,100 |
2023-05-25 | Powers Johnny D | Buy | 100,000 | .19 | 19,300 |
2021-11-18 | Powers Johnny D | Buy | 250,000 | .45 | 112,500 |
2021-06-15 | Powers Johnny D | Sale | 125,000 | .93 | 116,750 |
2021-06-15 | Powers Johnny D | Option Ex | 125,000 | .26 | 32,500 |
2021-06-01 | Cohen Robert (CEO) | Sale | 3,193,750 | .81 | 2,596,518 |
2021-06-01 | Cohen Robert (CEO) | Option Ex | 3,193,750 | .21 | 670,687 |
2021-05-03 | Cotter Ann Marie (CFO and Secretary) | Sale | 19,444 | 1.06 | 20,610 |
2021-05-03 | Cotter Ann Marie (CFO and Secretary) | Option Ex | 19,444 | .15 | 2,916 |
2021-04-12 | Cotter Ann Marie (CFO and Secretary) | Sale | 58,332 | 1.16 | 67,490 |
2021-04-12 | Cotter Ann Marie (CFO and Secretary) | Option Ex | 58,332 | .15 | 8,749 |
2021-04-12 | Morley Stephanie (President & CMO) | Sale | 805,000 | 1.16 | 931,385 |
2021-04-12 | Morley Stephanie (President & CMO) | Option Ex | 805,000 | .31 | 249,550 |
2021-04-12 | Powers Johnny D | Sale | 750,000 | 1.16 | 867,750 |
2021-04-12 | Powers Johnny D | Option Ex | 750,000 | .50 | 376,500 |
2021-02-03 | Macleod Christopher Ross | Sale | 6,400 | 1.10 | 7,046 |
2020-07-07 | Powers Johnny D | Buy | 625,000 | .16 | 100,000 |
2019-03-29 | Solensky Gerald Jr (President and CEO) | Option Ex | 65,789 | 1.52 | 99,999 |
2019-03-15 | Solensky Gerald Jr (President and CEO) | Option Ex | 164,473 | 1.52 | 249,998 |
2019-03-08 | Solensky Gerald Jr (President and CEO) | Option Ex | 164,473 | 1.52 | 249,998 |
2018-12-20 | Williams Rodney James | Option Ex | 26,900 | 1.20 | 32,280 |
2018-11-29 | Rowe Jeffrey M | Option Ex | 175,000 | 1.20 | 210,000 |
2018-10-11 | Solensky Gerald Jr (President and CEO) | Option Ex | 200,000 | 1.20 | 240,000 |
2018-08-28 | Lebar James | Sale | 200,000 | 2.15 | 430,000 |
2018-06-11 | Williams Rodney James | Sale | 1,000 | 1.92 | 1,920 |
2018-06-01 | Williams Rodney James | Sale | 500 | 1.93 | 965 |
2018-05-31 | Williams Rodney James | Sale | 1,500 | 1.91 | 2,865 |
2018-05-24 | Williams Rodney James | Sale | 500 | 1.92 | 960 |
2018-05-23 | Williams Rodney James | Sale | 500 | 1.93 | 963 |
2018-05-22 | Williams Rodney James | Sale | 500 | 1.93 | 965 |
2018-05-21 | Williams Rodney James | Sale | 500 | 2.02 | 1,007 |
2018-04-20 | Morley Stephanie (COO & VP of Product Dev) | Option Ex | 104,000 | .20 | 20,800 |
2018-03-29 | Morley Stephanie (COO & VP of Product Dev) | Option Ex | 500,000 | .20 | 100,000 |
2018-03-29 | Herbst Bruk (Chief Commercial Officer) | Option Ex | 62,996 | 2.20 | 138,591 |
2018-03-23 | Williams Rodney James | Option Ex | 140,000 | .20 | 28,000 |
2018-03-23 | Rowe Jeffrey M | Option Ex | 100,000 | .20 | 20,000 |
2018-03-12 | Shameze Rampertab (Chief Financial Officer) | Option Ex | 176,000 | .20 | 35,200 |
2018-01-24 | Lebar James | Option Ex | 100,000 | .20 | 20,000 |
2018-01-08 | Shameze Rampertab (Chief Financial Officer) | Option Ex | 124,000 | .20 | 24,800 |
2017-12-19 | Solensky Gerald Jr (President and CEO) | Option Ex | 750,000 | 1.20 | 900,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ZOMDF listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Zomedica Corp. (symbol ZOMDF, CIK number 1684144) see the Securities and Exchange Commission (SEC) website.